Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection
Authors:
- Zhen HuangZHZhen Huang
- Bo NingBNBo Ning
- He S. YangHYHe S. Yang
- Brady M. YoungquistBYBrady M. Youngquist
- Alex NiuANAlex Niu
- Christopher J. LyonCLChristopher J. Lyon
- Brandon J. BeddingfieldBBBrandon J. Beddingfield
- Alyssa C. FearsAFAlyssa C. Fears
- Chandler H. MonkCMChandler H. Monk
- Amelie E. MurrellAMAmelie E. Murrell
- Samantha J. BiltonSBSamantha J. Bilton
- Joshua P. LinhuberJLJoshua P. Linhuber
- 1 April 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 131 (7)
Abstract
BACKGROUND. Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA may represent a more reliable indicator of infection than nasal RNA, but quantitative reverse transcription PCR (RT-qPCR) lacks diagnostic sensitivity for blood samples. METHODS. A CRISPR-augmented RT-PCR assay that sensitively detects SARS-CoV-2 RNA was employed to analyze viral RNA kinetics in longitudinal plasma samples from nonhuman primates (NHPs) after virus exposure; to evaluate the utility of blood SARS-CoV-2 RNA detection for coronavirus disease 2019 (COVID-19) diagnosis in adults cases confirmed by nasal/nasopharyngeal swab RT-PCR results; and to identify suspected COVID-19 cases in pediatric and at-risk adult populations with negative nasal swab RT-qPCR results. All blood samples were analyzed by RT-qPCR to allow direct comparisons. RESULTS. CRISPR-augmented RT-PCR consistently detected SARS-CoV-2 RNA in the plasma of experimentally infected NHPs from 1 to 28 days after infection, and these increases preceded and correlated with rectal swab viral RNA increases. In a patient cohort (n = 159), this blood-based assay demonstrated 91.2% diagnostic sensitivity and 99.2% diagnostic specificity versus a comparator RT-qPCR nasal/nasopharyngeal test, whereas RT-qPCR exhibited 44.1% diagnostic sensitivity and 100% specificity for the same blood samples. This CRISPR-augmented RT-PCR assay also accurately identified patients with COVID-19 using one or more negative nasal swab RT-qPCR results. CONCLUSION. Results of this study indicate that sensitive detection of SARS-CoV-2 RNA in blood by CRISPR-augmented RT-PCR permits accurate COVID-19 diagnosis, and can detect COVID-19 cases with transient or negative nasal swab RT-qPCR results, suggesting that this approach could improve COVID-19 diagnosis and the evaluation of SARS-CoV-2 infection clearance, and predict the severity of infection. TRIAL REGISTRATION. ClinicalTrials.gov. NCT04358211. FUNDING. Department of Defense, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, and the National Center for Research Resources.Keywords
Funding Information
- U.S. Department of War (W8IXWH1910926)
- National Institute of Allergy and Infectious Diseases (HHSN272201700033I)
- National Institute of Child Health and Human Development (R01HD090927)
- National Center for Research Resources and the Office of Research Infrastructure Programs (OD011104)
- Tulane University (Weatherhead Presidential Endowment fund)
This publication has 41 references indexed in Scilit:
- Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood DonationsEmerging Infectious Diseases, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Positive RT-PCR Test Results in Patients Recovered From COVID-19JAMA, 2020
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Age‐related rhesus macaque models of COVID‐19Animal Models and Experimental Medicine, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumoniaEmerging Microbes & Infections, 2020
- Multiple organ infection and the pathogenesis of SARSJournal of Experimental Medicine, 2005